BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2596124)

  • 1. Histologic and clinical characteristics associated with rapidly progressive invasive cervical cancer: a preliminary report from the Yale Cancer Control Research Unit.
    Hadjimichael O; Janerich D; Lowell DM; Meigs JW; Merino MJ; Schwartz PE
    Yale J Biol Med; 1989; 62(4):345-50. PubMed ID: 2596124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapidly progressive cervical cancer: the Connecticut experience.
    Schwartz PE; Hadjimichael O; Lowell DM; Merino MJ; Janerich D
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 2):1105-9. PubMed ID: 8885794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cervicography: adjunctive cervical cancer screening by primary care clinicians.
    Ferris DG; Payne P; Frisch LE; Milner FH; diPaola FM; Petry LJ
    J Fam Pract; 1993 Aug; 37(2):158-64. PubMed ID: 8336097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of invasive cervical cancer after three consecutive negative Pap smears.
    Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
    J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears.
    Novotny DB; Maygarden SJ; Johnson DE; Frable WJ
    Acta Cytol; 1992; 36(1):1-10. PubMed ID: 1546503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior high-risk HPV testing and Pap test results for 427 invasive cervical cancers in China's largest CAP-certified laboratory.
    Zheng B; Li Z; Griffith CC; Yan S; Chen C; Ding X; Liang X; Yang H; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):428-34. PubMed ID: 25954852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical and vaginal cytologic smears suggestive of adenocarcinoma.
    Pretorius R; Binstock M; Sadeghi M; Hodges W
    J Reprod Med; 1996 Jul; 41(7):478-82. PubMed ID: 8829059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the clinical evaluation of atypical glandular cells of undetermined significance (AGCUS) detected on cervical cytology screening.
    Kennedy AW; Salmieri SS; Wirth SL; Biscotti CV; Tuason LJ; Travarca MJ
    Gynecol Oncol; 1996 Oct; 63(1):14-8. PubMed ID: 8898161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathologic Papanicolaou class IV smear without histologic correlation--what should be done?].
    Biedermann K; Bannwart F; Staikov D; Schreiner WE
    Geburtshilfe Frauenheilkd; 1988 Nov; 48(11):781-4. PubMed ID: 3234711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening errors in cervical cytologic screening.
    van der Graaf Y; Vooijs GP; Gaillard HL; Go DM
    Acta Cytol; 1987; 31(4):434-8. PubMed ID: 3604538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in protection against adenocarcinoma of the cervix resulting from participation in cervical screening.
    Mitchell H; Hocking J; Saville M
    Cancer; 2003 Dec; 99(6):336-41. PubMed ID: 14681940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer.
    Wallin KL; Wiklund F; Angström T; Bergman F; Stendahl U; Wadell G; Hallmans G; Dillner J
    N Engl J Med; 1999 Nov; 341(22):1633-8. PubMed ID: 10572150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endocervical curettage in colposcopy.
    Hatch KD; Shingleton HM; Orr JW; Gore H; Soong SJ
    Obstet Gynecol; 1985 Mar; 65(3):403-8. PubMed ID: 3974966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinician's guide to Pap smear interpretation.
    Mashburn J; Scharbo-DeHaan M
    Nurse Pract; 1997 Apr; 22(4):115-8, 124-7, 130 passim. PubMed ID: 9128882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
    Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of endocervical canal topography, tubal metaplasia, and high canal sampling on the cytologic presentation of nonneoplastic endocervical cells.
    Babkowski RC; Wilbur DC; Rutkowski MA; Facik MS; Bonfiglio TA
    Am J Clin Pathol; 1996 Apr; 105(4):403-10. PubMed ID: 8604682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The correlation of inflammation and epithelial changes in the Pap smears of cervix uteri].
    Kos M; Sarkanj-Golub R; Cupić H; Balicević D
    Acta Med Croatica; 2005; 59(4):297-302. PubMed ID: 16334735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with reduced accuracy in Papanicolaou tests for patients with invasive cervical cancer.
    Zhao L; Wentzensen N; Zhang RR; Dunn ST; Gold MA; Wang SS; Schiffman M; Walker JL; Zuna RE
    Cancer Cytopathol; 2014 Sep; 122(9):694-701. PubMed ID: 24888458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early endocervical glandular neoplasia. II. Morphometric analysis of the cells.
    Clark AH; Betsill WL
    Acta Cytol; 1986; 30(2):127-34. PubMed ID: 3457504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.